The Hamilton Rating Scale for Depression (HDRS) remains the most widely used assessment tool in psychiatry to quantify the severity of a depressive episode. Its interpretation goes beyond simply adding points: the composition of the score, the weighting of somatic items, and the clinical context radically alter the interpretation. Distinguishing between mild and severe depression using this scale requires an understanding of its limits as well as its thresholds.
Somatic Biases of the HDRS-17 and Impact on Total Score
The 17-item version includes several questions regarding sleep, appetite, gastrointestinal symptoms, and physical fatigue. In a patient suffering from a concurrent organic condition (chronic pain, hypothyroidism, sleep apnea), these somatic items artificially inflate the overall score. The total can then exceed the severity threshold without the mood component justifying it.
This bias necessitates cross-referencing the Hamilton score with the medical history. An item rated 2 for initial insomnia does not have the same clinical significance depending on whether it reflects anxious rumination or restless legs syndrome. We recommend always examining the score breakdown by domain before concluding on severity.
For this reason, some clinicians prefer the HDRS-6 version, which retains only six items focused on depressive mood, guilt, work and activities, psychomotor retardation, psychic anxiety, and general somatic symptoms. This shorter version reduces somatic noise and improves sensitivity to change under antidepressant treatment, while providing a tighter maximum score. To delve deeper into scoring and its nuances, the solutions proposed by Santé Boost detail each level of interpretation.
Hamilton Scoring Thresholds: What They Measure and What They Don’t Say
The thresholds typically used for the HDRS-17 divide the depressive spectrum into score ranges. These ranges guide therapeutic decisions, but they do not constitute absolute diagnostic boundaries.
- A score of 10 to 13 indicates mild depressive symptoms, often compatible with psychotherapy alone.
- Between 14 and 17, the symptomatology is classified as mild to moderate, where the question of introducing an antidepressant arises depending on functional impact.
- Above 18, symptoms are considered moderate to severe, generally justifying a combined pharmacological and psychotherapeutic approach.
The same total score can encompass very different clinical pictures. Two patients rated at 19 may present one with marked psychomotor retardation and profound anhedonia, while the other has predominant somatic anxiety with severe insomnia. The therapeutic approach will not be the same.
The NICE NG222 recommendation published in June 2022 emphasizes the distinction between symptom severity and functional impairment. A moderate Hamilton score associated with a total inability to maintain professional activity requires intensive management, while a higher score in a still functional patient may allow for a stepped strategy.
Assessment of Suicidal Risk Beyond Item 3
Item 3 of the HDRS rates suicide on a scale from 0 to 4, from the absence of ideation to an actual attempt. This single item does not constitute an assessment of suicidal risk. A patient may rate 1 (the impression that life is not worth living) while concealing a structured plan out of fear of hospitalization.
Therefore, the Hamilton rating must be supplemented by a targeted interview on active suicidal ideation, the existence of a plan, access to means, and protective factors. A global score of 12 with a suicide item rated at 3 (suicidal thoughts or actions) imposes a vigilance much greater than what a “mild” score might suggest.
This point is particularly critical in primary care, where the HDRS is sometimes administered in a short consultation time. The total score masks danger if item 3 is not analyzed in isolation.
Hamilton Scoring in Practice: Administration Conditions and Reproducibility
The HDRS is a hetero-questionnaire: it is the clinician who rates, not the patient. This characteristic distinguishes it from self-questionnaires like the PHQ-9 and introduces inter-rater variability. Two trained practitioners may diverge by several points on the same interview, particularly on items with subjective wording (depressive mood, psychic anxiety).
- The complete administration of the HDRS-17 requires a semi-structured interview, not just filling out a grid. Observing the patient’s non-verbal behavior is an integral part of the scoring.
- The scoring results in the CCAM code ALQP003, applicable once a year, highlighting its status as a formal clinical act.
- Reproducibility improves with training: a clinician who regularly uses the scale stabilizes their scoring over time.
An isolated score has limited value. Longitudinal monitoring of the Hamilton score under treatment provides much more reliable information than a snapshot at a given moment. A drop of several points between two evaluations spaced a few weeks apart confirms therapeutic response, regardless of the initial severity threshold.
Differentiating between mild and severe depression using the Hamilton scale requires going beyond a linear reading of the total score. The breakdown by domain, specific analysis of the suicidal item, consideration of somatic comorbidities, and longitudinal follow-up transform a raw number into a clinical decision-making tool. The score guides, clinical judgment decides.
